Pharma Ex-Exec Can't Revive $12M Underpayment Suit in US

By Jonathan Capriel · April 18, 2024, 7:32 PM EDT

A Manhattan federal judge has refused to rethink her decision tossing a $12 million suit accusing Altum Pharmaceuticals Inc. and its cannabis-focused parent company, BetterLife Pharma Inc., of stock dilution and...

To view the full article, register now.